Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.

Seiichiro KusuharaSatoshi IgawaMasaaki IchinoeRyo NagashioYuki KuchitsuYasuhiro HiyoshiKazu ShiomiYoshiki MurakumoMakoto SaegusaYukitoshi SatohYuichi Sato Katsuhiko Naoki

Published in: Thoracic cancer (2021)

GAL3 expression is a reliable biomarker to predict the prognosis of completely resected NSCLC patients receiving platinum-based AC.

Keyphrases

poor prognosis
small cell lung cancer
lymph node
advanced non small cell lung cancer
binding protein
long non coding rna
prognostic factors
brain metastases
epidermal growth factor receptor